Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
18 studies found for:    "glucose-6-phosphate dehydrogenase deficiency"
Show Display Options
RSS Create an RSS feed from your search for:
"glucose-6-phosphate dehydrogenase deficiency"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Comparing G6PD Tests Using Capillary Blood Versus Venous Blood
Condition: Glucose-6 Phosphate Dehydrogenase Deficiency
Intervention: Other: G6PD Test
2 Recruiting Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency
Conditions: G6PD Normal;   G6PD Deficient;   Healthy
Intervention: Drug: Regimens (Primaquine, Methylene blue)
3 Completed Evaluation of Different G6PD Testing Platforms
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention:
4 Completed A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Favism
Intervention: Drug: Primaquine
5 Completed Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Hyperbilirubinemia;   Hemolytic Disease of Newborn
Intervention: Drug: tin mesoporphyrin
6 Completed Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency
Condition: Acne Vulgaris
Interventions: Drug: ACZONE Gel, 5%;   Drug: Vehicle
7 Completed G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)
Condition: Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine;   Drug: Tafenoquine
8 Unknown  Erythrocyte and Adipocyte G6PD Activity Levels in Obesity
Conditions: Diabetes;   Obesity
Intervention:
9 Recruiting Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)
Condition: Malaria
Interventions: Drug: Artemether-Lumefantrine (AL) + 0.25 mg/kg primaquine;   Drug: Artemether-Lumefantrine (AL) combination;   Drug: Artemether-Lumefantrine (AL) + 0.4 mg/kg primaquine
10 Completed Examination of Protective Factors Against Severe Malaria
Conditions: Malaria;   Severe Malaria
Intervention:
11 Completed Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research
Conditions: Hemoglobin Mutations;   Erythrocyte Variants
Intervention:
12 Recruiting Primaquine Pharmacokinetics in Lactating Women and Their Infants
Condition: Vivax Malaria
Intervention: Drug: Primaquine
13 Completed Lapdap and Coartemether for Uncomplicated Malaria
Condition: Malaria
Interventions: Drug: Chlorproguanil-dapsone (Lapdap);   Drug: Lumefantrine-artemether (Coartemether )
14 Completed Malaria Studies in Cambodia
Condition: Malaria
Intervention:
15 Completed Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
Conditions: Hyperbilirubinemia;   Jaundice
Intervention: Procedure: Gene mutation sample
16 Completed Innate and Acquired Resistance to Plasmodium Falciparum Malaria in Mali
Condition: Malaria
Intervention:
17 Recruiting Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia
Conditions: Jaundice, Neonatal;   Hyperbilirubinemia, Neonatal
Interventions: Drug: stannsoporfin;   Drug: Placebo
18 Not yet recruiting Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Tafenoquine Placebo;   Drug: Chloroquine;   Drug: Primaquine;   Drug: Primaquine Placebo

Indicates status has not been verified in more than two years